• Elevate your connectivity with Multi-Core Infotech! Explore our top-notch optical fiber cable solutions designed for speed and reliability. From fiber routers to GPON ONTs and XPON ONUs, we’ve got everything to keep your network seamless.

    Need versatile ladders for your installation? Check out our durable extension ladder aluminium and aluminium telescopic ladder—perfect for any job!

    Plus, ensure your network's efficiency with our OTDR (Optical Time Domain Reflectometer) tools.

    Connect better, work smarter! #FiberOptics #MultiCoreInfotech #ConnectivitySolutions #Ladders #Technology
    https://multicoreinfotech.com/
    🌐✨ Elevate your connectivity with Multi-Core Infotech! Explore our top-notch optical fiber cable solutions designed for speed and reliability. From fiber routers to GPON ONTs and XPON ONUs, we’ve got everything to keep your network seamless. 🔧 Need versatile ladders for your installation? Check out our durable extension ladder aluminium and aluminium telescopic ladder—perfect for any job! 🔍 Plus, ensure your network's efficiency with our OTDR (Optical Time Domain Reflectometer) tools. Connect better, work smarter! 💻 #FiberOptics #MultiCoreInfotech #ConnectivitySolutions #Ladders #Technology https://multicoreinfotech.com/
    0 Yorumlar 0 hisse senetleri 64 Views
  • Metal Beach Chair Durability
    Metal beach chairs are known for their metal material, which is highly durable. Metal beach chairs are usually made of stainless steel, aluminum alloy, or other high-strength alloys, which are highly resistant to corrosion, rust, and UV rays. In an outdoor environment, metal beach chairs can withstand wind and rain, maintaining their stability and durability even on wet sand.
    Durability depends largely on the materials used. High-quality camping chairs usually use durable materials such as high-strength steel pipes, aluminum alloys, nylon or polyester fibers. These materials can withstand greater pressure and impact, and at the same time have good corrosion resistance and anti-aging properties, ensuring that the chairs have a long service life in outdoor environments.
    https://www.bjgardencn.com/product/metal-beach-chair/
    Metal Beach Chair Durability Metal beach chairs are known for their metal material, which is highly durable. Metal beach chairs are usually made of stainless steel, aluminum alloy, or other high-strength alloys, which are highly resistant to corrosion, rust, and UV rays. In an outdoor environment, metal beach chairs can withstand wind and rain, maintaining their stability and durability even on wet sand. Durability depends largely on the materials used. High-quality camping chairs usually use durable materials such as high-strength steel pipes, aluminum alloys, nylon or polyester fibers. These materials can withstand greater pressure and impact, and at the same time have good corrosion resistance and anti-aging properties, ensuring that the chairs have a long service life in outdoor environments. https://www.bjgardencn.com/product/metal-beach-chair/
    High Quality Beach Chair Manufacturer In China Exporter Maker Price
    The Beach Chair Is A Versatile Outdoor Seating Option Designed For Beach And Sunny Vacations, It Is Made With A Durable Metal Frame And Weather-Resistant Fabric For Comfort And Durability, Chair Designs Often Include Reclining Backrests, Armrests, And Sometimes Built-In Shades.
    0 Yorumlar 0 hisse senetleri 389 Views
  • Make every reflection crystal-clear with Hellamaid in Calgary! Pro tip: Use a solution of vinegar and water for streak-free mirrors, and polish with a microfiber cloth for a flawless finish. Experience the magic of pristine mirrors and a sparkling home with Hellamaid today!
    https://hellamaid.ca/house-cleaning-services-calgary/
    #MirrorMagic #CalgaryCleaning #Hellamaid
    🌟✨ Make every reflection crystal-clear with Hellamaid in Calgary! Pro tip: Use a solution of vinegar and water for streak-free mirrors, and polish with a microfiber cloth for a flawless finish. Experience the magic of pristine mirrors and a sparkling home with Hellamaid today! https://hellamaid.ca/house-cleaning-services-calgary/ ✨🌟 #MirrorMagic #CalgaryCleaning #Hellamaid
    Like
    1
    0 Yorumlar 0 hisse senetleri 950 Views
  • RexrayTapijten - De PersTapijten | Handwoven Carpets and Rugs
    https://www.depers-tapijten.com/index.php/rexray%20tapijten.html
    Explore our collection of handwoven RexrayTapijten at De PersTapijten. Choose from a range of traditional and modern designs in wool, silk, and natural fibers. Find the perfect carpet or rug for your home decor and interior design.
    RexrayTapijten - De PersTapijten | Handwoven Carpets and Rugs https://www.depers-tapijten.com/index.php/rexray%20tapijten.html Explore our collection of handwoven RexrayTapijten at De PersTapijten. Choose from a range of traditional and modern designs in wool, silk, and natural fibers. Find the perfect carpet or rug for your home decor and interior design.
    0 Yorumlar 0 hisse senetleri 1637 Views
  • Handwoven Chobi Carpets | De PersTapijten
    https://www.depers-tapijten.com/index.php/chobi.html
    Shop our collection of handwoven Chobi carpets, crafted with exquisite detail and made from the finest natural fibers. Find the perfect addition to your home's decor at De PersTapijten.
    Handwoven Chobi Carpets | De PersTapijten https://www.depers-tapijten.com/index.php/chobi.html Shop our collection of handwoven Chobi carpets, crafted with exquisite detail and made from the finest natural fibers. Find the perfect addition to your home's decor at De PersTapijten.
    0 Yorumlar 0 hisse senetleri 737 Views
  • The global nanocellulose market size is anticipated to showcase potential growth owing to the increasing concerns regarding the sustainability of the packaging industry, observes Fortune Business Insights™ in its report, Nanocellulose has applications in various industries including cement and composites, textile, and paper and packaging. The market stood at USD 291.53 million in 2019 and is projected to reach USD 1,053.09 million by 2027 at a CAGR of 19.9% in the forecast period.

    Information Source - https://www.fortunebusinessinsights.com/nanocellulose-market-104565

    Highlights of the Report:

    While making the report, we segmented the market on the basis of product, type, consumption, distribution channel, and region. Based on the segmentation, we made a list of companies and conducted a detailed analysis of their financial positions, product portfolios, and growth strategies. Our next step included the study of core competencies of key players and their market share to anticipate the degree of competition. The bottom-up procedure was conducted to arrive at the overall size of the market.

    Drivers & Restraints-

    Increasing Applications in Packaging Industry to Drive Growth

    Rising concerns regarding the impact of material used by the packaging industry on the environment are estimated to drive nanocellulose market growth. For instance, according to the U.S. Environmental Protection Agency, packaging material accounts for around 28.1% of the total municipal solid waste in the U.S. and the material used in packaging includes plastic, which is non-degradable. In addition, the extensive utilization of nano cellulose in the textile industry is projected to further strengthen its demand. However, the high cost of production associated with the product is expected to limit the growth of nanocellulose.

    Segment-

    Paper and Packaging to Be the Fastest-growing Segment

    Based on the application, paper and packaging is estimated to be the fastest-growing segment with a market share of 23.0% in 2019. Increasing the utilization of cellulose nanocrystals in both paper and plastic-based packaging is driving the segment growth. Additionally, the segment held a share of 22.4% in Germany.

    Based on type, the microfibrillated cellulose (MFC) segment is anticipated to hold a considerable nanocellulose market share owing to its applications in the manufacturing of nanocomposites, bio-based medical products, wood adhesives, super-capacitors, batteries, continuous fibers for textiles, and other products.

    Regional Insights-

    High Availability of Wood in Eastern Europe to Help the Region Dominate

    Europe is projected to dominate the global market with a value of USD 108.77 million in 2019. Its dominance is attributed to the high concentration of manufacturers in the region owing to the rising availability of wood in the Eastern Europe. In addition, the region is a manufacturing hub of automobiles, textiles, and cosmetics, which is estimated to further drive the growth of nanocellulose.

    The market in Asia Pacific is not far behind as it is set to exhibit substantial growth in the forecast timeline with a value of USD 43.16 million in 2019. The presence of end-use industries, such as food, cement, textiles, and paper in China, South Korea, and India is anticipated to propel the demand for nanocellulose, driving its growth in the region.

    Competitive Landscape-

    Research & Development to Aid Key Players Develop Innovative Products

    Key players operating in the global market are investing extensively in research and development in order to develop innovative products based on nanocellulose and upgrade the existing ones. This will help them gain prominence over other companies. For instance, in December 2020, Norske Skog announced the development of a new variant of CEBINA by replacing the suspension liquid with polymer instead of water. This enabled the use of CEBINA in epoxy floor coverings and adhesives.

    Industry Developments-

    In April 2020, Celluforce announced that Celluforce NCC, a gelling agent produced by the company, is suitable for the manufacturing of hydro-alcoholic gels, thereby replacing the traditionally used acrylates and carbomers. This makes the agent suitable in making gel-based sanitizers while providing an invisible layer of cellulose on hands for protecting damaged skin.
    In February 2020: GranBio Technologies, a subsidiary of GranBio, signed a supply partnership with Birla Carbon, an Indian company. Under this agreement, Birla Carbon will supply biomass-based nanocellulose for the replacement of carbon black, an oil by-product used in the tire & rubber industry.
    A List of Key Manufacturers Operating in the Market:

    Fiberlean Technologies (UK)
    Kruger, Inc. (Canada)
    Borregard (Norway)
    Nippon Paper Group (Japan)
    Celluforce (Canada)
    Stora Enso (Finland)
    Norske Skog ASA (Norway)
    The University of Maine (U.S.)
    Research Institutes of Sweden (RISE) (Sweden)
    GranBio (Brazil)
    CelluComp (UK)
    Other Key Players
    The global nanocellulose market size is anticipated to showcase potential growth owing to the increasing concerns regarding the sustainability of the packaging industry, observes Fortune Business Insights™ in its report, Nanocellulose has applications in various industries including cement and composites, textile, and paper and packaging. The market stood at USD 291.53 million in 2019 and is projected to reach USD 1,053.09 million by 2027 at a CAGR of 19.9% in the forecast period. Information Source - https://www.fortunebusinessinsights.com/nanocellulose-market-104565 Highlights of the Report: While making the report, we segmented the market on the basis of product, type, consumption, distribution channel, and region. Based on the segmentation, we made a list of companies and conducted a detailed analysis of their financial positions, product portfolios, and growth strategies. Our next step included the study of core competencies of key players and their market share to anticipate the degree of competition. The bottom-up procedure was conducted to arrive at the overall size of the market. Drivers & Restraints- Increasing Applications in Packaging Industry to Drive Growth Rising concerns regarding the impact of material used by the packaging industry on the environment are estimated to drive nanocellulose market growth. For instance, according to the U.S. Environmental Protection Agency, packaging material accounts for around 28.1% of the total municipal solid waste in the U.S. and the material used in packaging includes plastic, which is non-degradable. In addition, the extensive utilization of nano cellulose in the textile industry is projected to further strengthen its demand. However, the high cost of production associated with the product is expected to limit the growth of nanocellulose. Segment- Paper and Packaging to Be the Fastest-growing Segment Based on the application, paper and packaging is estimated to be the fastest-growing segment with a market share of 23.0% in 2019. Increasing the utilization of cellulose nanocrystals in both paper and plastic-based packaging is driving the segment growth. Additionally, the segment held a share of 22.4% in Germany. Based on type, the microfibrillated cellulose (MFC) segment is anticipated to hold a considerable nanocellulose market share owing to its applications in the manufacturing of nanocomposites, bio-based medical products, wood adhesives, super-capacitors, batteries, continuous fibers for textiles, and other products. Regional Insights- High Availability of Wood in Eastern Europe to Help the Region Dominate Europe is projected to dominate the global market with a value of USD 108.77 million in 2019. Its dominance is attributed to the high concentration of manufacturers in the region owing to the rising availability of wood in the Eastern Europe. In addition, the region is a manufacturing hub of automobiles, textiles, and cosmetics, which is estimated to further drive the growth of nanocellulose. The market in Asia Pacific is not far behind as it is set to exhibit substantial growth in the forecast timeline with a value of USD 43.16 million in 2019. The presence of end-use industries, such as food, cement, textiles, and paper in China, South Korea, and India is anticipated to propel the demand for nanocellulose, driving its growth in the region. Competitive Landscape- Research & Development to Aid Key Players Develop Innovative Products Key players operating in the global market are investing extensively in research and development in order to develop innovative products based on nanocellulose and upgrade the existing ones. This will help them gain prominence over other companies. For instance, in December 2020, Norske Skog announced the development of a new variant of CEBINA by replacing the suspension liquid with polymer instead of water. This enabled the use of CEBINA in epoxy floor coverings and adhesives. Industry Developments- In April 2020, Celluforce announced that Celluforce NCC, a gelling agent produced by the company, is suitable for the manufacturing of hydro-alcoholic gels, thereby replacing the traditionally used acrylates and carbomers. This makes the agent suitable in making gel-based sanitizers while providing an invisible layer of cellulose on hands for protecting damaged skin. In February 2020: GranBio Technologies, a subsidiary of GranBio, signed a supply partnership with Birla Carbon, an Indian company. Under this agreement, Birla Carbon will supply biomass-based nanocellulose for the replacement of carbon black, an oil by-product used in the tire & rubber industry. A List of Key Manufacturers Operating in the Market: Fiberlean Technologies (UK) Kruger, Inc. (Canada) Borregard (Norway) Nippon Paper Group (Japan) Celluforce (Canada) Stora Enso (Finland) Norske Skog ASA (Norway) The University of Maine (U.S.) Research Institutes of Sweden (RISE) (Sweden) GranBio (Brazil) CelluComp (UK) Other Key Players
    Nanocellulose Market Size & Growth | Global Report [2020-2027]
    The global nanocellulose market size was USD 291.53 million in 2019 and is projected to reach USD 1,053.09 million by 2027, exhibiting an exhilarating CAGR of 19.9% during the forecast period.
    0 Yorumlar 0 hisse senetleri 4024 Views
  • PSYCHOSIS-
    Antibiotics and the Brain: It’s Complicated.
    Antibiotics can both cause and cure psychosis.
    Reviewed by Davia Sills

    KEY POINTS-
    Antibiotics can decimate a person's gut microbes.
    An altered microbiota can affect one's mood and cognition.
    It may soon be possible to mitigate the damaging effects of antibiotics on the gut.
    “Vaccines and antibiotics have made many infectious diseases a thing of the past; we've come to expect that public health and modern science can conquer all microbes. But nature is a formidable adversary.” — Tom Frieden

    Antibiotics are a bona-fide medical miracle. When it comes to bacterial infections, nothing compares. Antibiotics have saved millions of lives. Got a cut? Antibiotics. Got strep throat? Antibiotics. Got a cold? Antibiotics. I threw in the last one to see if you are paying attention. Colds are caused by viruses, not bacteria, and antibiotics won’t help even a tiny bit. But so what? Better safe than sorry, right?

    The Bad
    However, antibiotics have a dark side, and you should be aware of it. Scientists have long known about a direct connection between acute psychosis and certain antibiotics, including penicillin, fluoroquinolones, cephalosporins, and macrolides.

    This turns out to be tricky to measure: The reason that antibiotics are administered is because of infection or inflammation, which can itself lead to psychosis. However, causality has been established in cases where the psychosis lifted when the antibiotics were stopped and returned when the antibiotics were resumed.

    This isn’t a new finding; doctors have documented a wide variety of mental complications with penicillin since 1945. The list of symptoms is long, including seizures, aphasia, spasms, psychosis, confusion, lethargy, anxiety, and coma.

    The How
    It’s not just penicillin: The documented psychiatric side effects of antibiotics other than penicillin range from mild symptoms to severe delirium and psychosis. What is this mysterious connection between antibiotics and the brain? The prime suspect is the gut microbiota—the batch of microbes that live in our gut and help us with digestion and defense against pathogens.

    Oral antibiotics can seriously damage the microbiota. That is, after all, the whole point of antibiotics: killing bacteria. Studies have shown that your microbiota can affect your brain via the gut-brain axis. Antibiotics can kill bacteria that produce neurotransmitters like GABA, dopamine, and serotonin, and that may affect your cognition and mood. The good news here is that when the antibiotics are discontinued, the mental issues typically resolve quickly.

    Challenges to the microbiota can be especially impactful for children. The first 1,000 days of our childhood are special. That’s when our immune system must learn to tolerate our beneficial bacteria. Although the details are still murky, the job must get done, or we will forever be fighting our helpful microbes, setting us up for long-term inflammation.

    Getting it right is important for more than just our gut: A proper microbiota helps the brain to develop normally as well. Giving antibiotics during this accommodation period risks killing the bacteria we need. In mice, a lack of bacteria can cause an abnormal stress reaction. Providing those mice with a healthy microbiota puts them back on track, but only if they are younger than three weeks. After that, their stress response can’t recover.

    Humans are not mice, but infants who take antibiotics have a less diverse microbiota and are more likely to get IBD and depression as adults. If your child really needs them, don’t hold back, but keep in mind that there might be long-term consequences.

    The Good
    In 1882, Robert Koch discovered that tuberculosis was caused by bacteria, and soon sanatoriums were established to deal with contagious patients. People with TB are often depressed, and sanatoriums are typically quiet, somber places.

    In 1951, researchers decided to trial a new antibiotic, called isoniazid, to treat TB bacteria. To their surprise, the patients reacted weirdly: They started laughing and dancing in the hallways. The staff found themselves shushing their normally reserved patients. The researchers realized that, by pure serendipity, they had discovered the first antidepressant.

    They found that isoniazid prevented the breakdown of neurotransmitters, including serotonin, dopamine, and epinephrine. The race was on to find new drugs that could affect neurotransmitters. That focus ultimately led to all the modern antidepressants, including Prozac, Wellbutrin, Zoloft, and others.

    Virtually forgotten in all the hoopla: isoniazid is an antibiotic. As well as lifting mood, the drug alters the microbiota. This was an early glimpse at the connection between microbes and brain function, but it was swiftly forgotten.

    Another win for antibiotics and mood is hepatic encephalopathy, a liver problem that affects the brain. It can cause anxiety and profound personality changes. It is not new: Hippocrates made a note of patients with liver disease and bad tempers. He said, “Those who are mad on account of bile are vociferous, vicious, and do not keep quiet.”

    The culprit is ammonia, which causes edema in the brain. If untreated, it can lead to coma and death. Ammonia is a product of certain gut bacteria. One treatment is lactulose, a sugar that is consumed by lactobacillus bacteria, which multiplies and produces lactic acid. That increased acidity kills off many of those ammonia producers.

    Another treatment is rifaximin, an antibiotic that acts directly on gut bacteria. The ability to treat this particular psychosis with antibiotics is another reminder of the unexpected impact our gut bacteria have on our brains.

    The Confusing
    In third-world countries where infections are endemic, taking antibiotics while pregnant can increase the odds that the baby will have a healthy birth weight. But in high-income countries, antibiotic use during pregnancy is associated with low birth weight. Why is that?

    Most mothers don’t know it, but they pass on more than their own genes to their children: They pass down microbial genes as well. So, when the mom gets sick or takes antibiotics, it can affect this microbial heritage. Maternal infections and antibiotic use during pregnancy are associated with increased rates of schizophrenia, autism, anxiety, and depression later in the child’s life.

    Before you despair, remember that associations don’t imply causality, and antibiotics during pregnancy can save the life of both the mother and the baby. But it’s worth keeping in mind that broad-spectrum antibiotics may also damage the microbiota in a way that could have a lasting effect on the child.

    The Upshot
    Antibiotics will degrade some bacterial species, which will allow others to fill the ranks. In a balanced microbiota, these new recruits are good neighbors. But when they are allowed to bloom, they can produce dysbiosis. When you are taking antibiotics, you don’t want to encourage their overgrowth. You may not want prebiotic fiber to amplify the uncertain survivors of an antibiotic battle. Better to eat simple foods like rice and bananas until the antibiotic treatment is over.

    When you stop taking antibiotics, you need to restore your friendly old neighborhood of microbes. Your best bet here is to eat a wide diversity of foods with lots of different colorful polyphenols and various types of fiber. A prebiotic blend could be a useful supplement if you can’t get enough diversity of vegetables. A Mediterranean-style diet is a great way to recoup from antibiotic treatment. It’s also delicious.

    Alcohol can exacerbate a leaky gut, so use it sparingly. Sodas, candy, and other sweets will feed fungi. Bacteria and fungi have a complex relationship, but when antibiotics knock out bacteria, fungi enjoy a resurgence due to less competition. Fungal overgrowth can be tough to control, so don’t encourage it.

    The future
    A German study conducted by Lisa Maier, Camille Goemans, and colleagues from the European Molecular Biology Laboratory gives some hope for a better antibiotic outcome. The researchers looked at 144 different antibiotics and monitored how they affected specific gut bacteria. They discovered that several unexpected drugs could protect the gut microbiota against antibiotic damage. These include dicumarol (an anticoagulant), benzbromarone (a gout medication), tolfenamic acid, and diflunisal (anti-inflammatories).

    These drugs allowed the antibiotics to attack their targets without killing beneficial bacteria. Maier says this novel approach, combining antibiotics with protective drugs, could reduce the harmful side effects of antibiotics, including psychosis. It will, however, take time to become a standard protocol.

    Antibiotics are amazing drugs that have saved millions of lives, but in nature, nothing is black and white. The stories told here demonstrate that the gut-brain connection is vulnerable to antibiotics. That’s an important factor to consider the next time you get an infection.
    PSYCHOSIS- Antibiotics and the Brain: It’s Complicated. Antibiotics can both cause and cure psychosis. Reviewed by Davia Sills KEY POINTS- Antibiotics can decimate a person's gut microbes. An altered microbiota can affect one's mood and cognition. It may soon be possible to mitigate the damaging effects of antibiotics on the gut. “Vaccines and antibiotics have made many infectious diseases a thing of the past; we've come to expect that public health and modern science can conquer all microbes. But nature is a formidable adversary.” — Tom Frieden Antibiotics are a bona-fide medical miracle. When it comes to bacterial infections, nothing compares. Antibiotics have saved millions of lives. Got a cut? Antibiotics. Got strep throat? Antibiotics. Got a cold? Antibiotics. I threw in the last one to see if you are paying attention. Colds are caused by viruses, not bacteria, and antibiotics won’t help even a tiny bit. But so what? Better safe than sorry, right? The Bad However, antibiotics have a dark side, and you should be aware of it. Scientists have long known about a direct connection between acute psychosis and certain antibiotics, including penicillin, fluoroquinolones, cephalosporins, and macrolides. This turns out to be tricky to measure: The reason that antibiotics are administered is because of infection or inflammation, which can itself lead to psychosis. However, causality has been established in cases where the psychosis lifted when the antibiotics were stopped and returned when the antibiotics were resumed. This isn’t a new finding; doctors have documented a wide variety of mental complications with penicillin since 1945. The list of symptoms is long, including seizures, aphasia, spasms, psychosis, confusion, lethargy, anxiety, and coma. The How It’s not just penicillin: The documented psychiatric side effects of antibiotics other than penicillin range from mild symptoms to severe delirium and psychosis. What is this mysterious connection between antibiotics and the brain? The prime suspect is the gut microbiota—the batch of microbes that live in our gut and help us with digestion and defense against pathogens. Oral antibiotics can seriously damage the microbiota. That is, after all, the whole point of antibiotics: killing bacteria. Studies have shown that your microbiota can affect your brain via the gut-brain axis. Antibiotics can kill bacteria that produce neurotransmitters like GABA, dopamine, and serotonin, and that may affect your cognition and mood. The good news here is that when the antibiotics are discontinued, the mental issues typically resolve quickly. Challenges to the microbiota can be especially impactful for children. The first 1,000 days of our childhood are special. That’s when our immune system must learn to tolerate our beneficial bacteria. Although the details are still murky, the job must get done, or we will forever be fighting our helpful microbes, setting us up for long-term inflammation. Getting it right is important for more than just our gut: A proper microbiota helps the brain to develop normally as well. Giving antibiotics during this accommodation period risks killing the bacteria we need. In mice, a lack of bacteria can cause an abnormal stress reaction. Providing those mice with a healthy microbiota puts them back on track, but only if they are younger than three weeks. After that, their stress response can’t recover. Humans are not mice, but infants who take antibiotics have a less diverse microbiota and are more likely to get IBD and depression as adults. If your child really needs them, don’t hold back, but keep in mind that there might be long-term consequences. The Good In 1882, Robert Koch discovered that tuberculosis was caused by bacteria, and soon sanatoriums were established to deal with contagious patients. People with TB are often depressed, and sanatoriums are typically quiet, somber places. In 1951, researchers decided to trial a new antibiotic, called isoniazid, to treat TB bacteria. To their surprise, the patients reacted weirdly: They started laughing and dancing in the hallways. The staff found themselves shushing their normally reserved patients. The researchers realized that, by pure serendipity, they had discovered the first antidepressant. They found that isoniazid prevented the breakdown of neurotransmitters, including serotonin, dopamine, and epinephrine. The race was on to find new drugs that could affect neurotransmitters. That focus ultimately led to all the modern antidepressants, including Prozac, Wellbutrin, Zoloft, and others. Virtually forgotten in all the hoopla: isoniazid is an antibiotic. As well as lifting mood, the drug alters the microbiota. This was an early glimpse at the connection between microbes and brain function, but it was swiftly forgotten. Another win for antibiotics and mood is hepatic encephalopathy, a liver problem that affects the brain. It can cause anxiety and profound personality changes. It is not new: Hippocrates made a note of patients with liver disease and bad tempers. He said, “Those who are mad on account of bile are vociferous, vicious, and do not keep quiet.” The culprit is ammonia, which causes edema in the brain. If untreated, it can lead to coma and death. Ammonia is a product of certain gut bacteria. One treatment is lactulose, a sugar that is consumed by lactobacillus bacteria, which multiplies and produces lactic acid. That increased acidity kills off many of those ammonia producers. Another treatment is rifaximin, an antibiotic that acts directly on gut bacteria. The ability to treat this particular psychosis with antibiotics is another reminder of the unexpected impact our gut bacteria have on our brains. The Confusing In third-world countries where infections are endemic, taking antibiotics while pregnant can increase the odds that the baby will have a healthy birth weight. But in high-income countries, antibiotic use during pregnancy is associated with low birth weight. Why is that? Most mothers don’t know it, but they pass on more than their own genes to their children: They pass down microbial genes as well. So, when the mom gets sick or takes antibiotics, it can affect this microbial heritage. Maternal infections and antibiotic use during pregnancy are associated with increased rates of schizophrenia, autism, anxiety, and depression later in the child’s life. Before you despair, remember that associations don’t imply causality, and antibiotics during pregnancy can save the life of both the mother and the baby. But it’s worth keeping in mind that broad-spectrum antibiotics may also damage the microbiota in a way that could have a lasting effect on the child. The Upshot Antibiotics will degrade some bacterial species, which will allow others to fill the ranks. In a balanced microbiota, these new recruits are good neighbors. But when they are allowed to bloom, they can produce dysbiosis. When you are taking antibiotics, you don’t want to encourage their overgrowth. You may not want prebiotic fiber to amplify the uncertain survivors of an antibiotic battle. Better to eat simple foods like rice and bananas until the antibiotic treatment is over. When you stop taking antibiotics, you need to restore your friendly old neighborhood of microbes. Your best bet here is to eat a wide diversity of foods with lots of different colorful polyphenols and various types of fiber. A prebiotic blend could be a useful supplement if you can’t get enough diversity of vegetables. A Mediterranean-style diet is a great way to recoup from antibiotic treatment. It’s also delicious. Alcohol can exacerbate a leaky gut, so use it sparingly. Sodas, candy, and other sweets will feed fungi. Bacteria and fungi have a complex relationship, but when antibiotics knock out bacteria, fungi enjoy a resurgence due to less competition. Fungal overgrowth can be tough to control, so don’t encourage it. The future A German study conducted by Lisa Maier, Camille Goemans, and colleagues from the European Molecular Biology Laboratory gives some hope for a better antibiotic outcome. The researchers looked at 144 different antibiotics and monitored how they affected specific gut bacteria. They discovered that several unexpected drugs could protect the gut microbiota against antibiotic damage. These include dicumarol (an anticoagulant), benzbromarone (a gout medication), tolfenamic acid, and diflunisal (anti-inflammatories). These drugs allowed the antibiotics to attack their targets without killing beneficial bacteria. Maier says this novel approach, combining antibiotics with protective drugs, could reduce the harmful side effects of antibiotics, including psychosis. It will, however, take time to become a standard protocol. Antibiotics are amazing drugs that have saved millions of lives, but in nature, nothing is black and white. The stories told here demonstrate that the gut-brain connection is vulnerable to antibiotics. That’s an important factor to consider the next time you get an infection.
    Like
    1
    0 Yorumlar 0 hisse senetleri 2072 Views
  • TRAUMA-
    The Pandemic Is Not Over.
    What have we learned over the past three years.
    Reviewed by Abigail Fagan

    This is not the time to let down our defenses, with over 120,000 new cases and 1,700 deaths caused by COVID each week in the U.S. Regrettably, only 16.7% of Americans have updated booster doses. SARS-CoV-2 not only induces respiratory symptoms but can affect multiple organ systems, including the kidneys, gastrointestinal tract, heart, and brain. SARS-CoV-2 is known to cause strokes, venous sinus thrombosis, encephalitis, and acute sensorimotor neuropathies. There have been over 760 million confirmed cases of COVID-19 as of April (World Health Organization, 2023). Most persons infected with SARS-CoV-2 remain asymptomatic, but many experience mild (40%) or moderate (40%) disease. Approximately 15% develop severe COVID-19 that requires oxygen support. An 18-month follow-up of those with symptomatic infections found that 6% had not recovered and 42% had recovered only partially.

    Clues are beginning to emerge as to why some have persisting symptoms following COVID-19. There is a higher risk of Long COVID in those with a more severe initial infection, but Long COVID can occur even after a mild infection. Risk factors for developing Long COVID include the presence of Epstein Barr virus, SARS-CoV-2 virus, certain auto-antibodies, diabetes type II, obesity, high blood pressure, chronic lung disease, and depression.

    For example, the lingering symptoms of difficulty thinking may be caused by ongoing low-grade brain inflammation following the acute viral infection, and even individuals with initial mild COVID symptoms may be vulnerable. While there is no evidence of widespread SARS-CoV-2 infection in the brain, many neurological symptoms of Long COVID-19 are likely a result of a post-inflammatory response including the presence of antibodies that react with the nervous system. The inflammatory response occurs particularly around blood vessels, with macrophages producing free radicals and cytokines that persist and cause damage.

    Finally, COVID-19 infection can also cause some arteries and veins in the brain to become thin; breaks in small blood vessels can cause bleeding in the brain. COVID-19 can also cause blood cells to form clots in arteries and veins which reduce or block the flow of blood, oxygen, and nutrients that cells need to function and can lead to a stroke. In sum, the inflammatory immune system response to the virus, injury to blood vessels, and lack of oxygen in the brain may account for diagnostic images that show changes in the brain’s white matter that contains the long nerve fibers, which transfer information from one brain region to another. This “diffuse white matter disease” might contribute to cognitive difficulties.

    The neurocognitive problems that intensify over time in some patients with Long COVID are similar to those in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Several studies have indicated that about 40% of patients with Long COVID fulfilled ME/CFS criteria. The clinical similarities between ME/CFS and ME/CFS-Long COVID allow us to suggest common pathobiology. With Long COVID, there is evidence that the initial SARS-CoV-2 infection reactivates latent viruses such as Epstein Barr virus, which has been linked to many other illnesses including multiple sclerosis. By studying those who test negative for SARS-CoV-2, but have ME/CFS, we could learn more about the relationship between Epstein Barr Virus and both Long COVID and ME/CFS.

    A recent book by international scholars around the world, edited in part by one of us, Leonard Jason, Understanding the Behavioral and Medical Impact of Long COVID, describes what is known in different areas of functioning affected by Long COVID and how this knowledge can facilitate the application of appropriate assessment and treatment. There are clear benefits that can occur when multidisciplinary approaches can help better understand the complicated behavioral and medical systems of those affected by Long COVID. We all remain at risk for this deadly virus, and we need to continue to exercise caution and engage in safe behaviors to protect ourselves and our loved ones.
    TRAUMA- The Pandemic Is Not Over. What have we learned over the past three years. Reviewed by Abigail Fagan This is not the time to let down our defenses, with over 120,000 new cases and 1,700 deaths caused by COVID each week in the U.S. Regrettably, only 16.7% of Americans have updated booster doses. SARS-CoV-2 not only induces respiratory symptoms but can affect multiple organ systems, including the kidneys, gastrointestinal tract, heart, and brain. SARS-CoV-2 is known to cause strokes, venous sinus thrombosis, encephalitis, and acute sensorimotor neuropathies. There have been over 760 million confirmed cases of COVID-19 as of April (World Health Organization, 2023). Most persons infected with SARS-CoV-2 remain asymptomatic, but many experience mild (40%) or moderate (40%) disease. Approximately 15% develop severe COVID-19 that requires oxygen support. An 18-month follow-up of those with symptomatic infections found that 6% had not recovered and 42% had recovered only partially. Clues are beginning to emerge as to why some have persisting symptoms following COVID-19. There is a higher risk of Long COVID in those with a more severe initial infection, but Long COVID can occur even after a mild infection. Risk factors for developing Long COVID include the presence of Epstein Barr virus, SARS-CoV-2 virus, certain auto-antibodies, diabetes type II, obesity, high blood pressure, chronic lung disease, and depression. For example, the lingering symptoms of difficulty thinking may be caused by ongoing low-grade brain inflammation following the acute viral infection, and even individuals with initial mild COVID symptoms may be vulnerable. While there is no evidence of widespread SARS-CoV-2 infection in the brain, many neurological symptoms of Long COVID-19 are likely a result of a post-inflammatory response including the presence of antibodies that react with the nervous system. The inflammatory response occurs particularly around blood vessels, with macrophages producing free radicals and cytokines that persist and cause damage. Finally, COVID-19 infection can also cause some arteries and veins in the brain to become thin; breaks in small blood vessels can cause bleeding in the brain. COVID-19 can also cause blood cells to form clots in arteries and veins which reduce or block the flow of blood, oxygen, and nutrients that cells need to function and can lead to a stroke. In sum, the inflammatory immune system response to the virus, injury to blood vessels, and lack of oxygen in the brain may account for diagnostic images that show changes in the brain’s white matter that contains the long nerve fibers, which transfer information from one brain region to another. This “diffuse white matter disease” might contribute to cognitive difficulties. The neurocognitive problems that intensify over time in some patients with Long COVID are similar to those in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Several studies have indicated that about 40% of patients with Long COVID fulfilled ME/CFS criteria. The clinical similarities between ME/CFS and ME/CFS-Long COVID allow us to suggest common pathobiology. With Long COVID, there is evidence that the initial SARS-CoV-2 infection reactivates latent viruses such as Epstein Barr virus, which has been linked to many other illnesses including multiple sclerosis. By studying those who test negative for SARS-CoV-2, but have ME/CFS, we could learn more about the relationship between Epstein Barr Virus and both Long COVID and ME/CFS. A recent book by international scholars around the world, edited in part by one of us, Leonard Jason, Understanding the Behavioral and Medical Impact of Long COVID, describes what is known in different areas of functioning affected by Long COVID and how this knowledge can facilitate the application of appropriate assessment and treatment. There are clear benefits that can occur when multidisciplinary approaches can help better understand the complicated behavioral and medical systems of those affected by Long COVID. We all remain at risk for this deadly virus, and we need to continue to exercise caution and engage in safe behaviors to protect ourselves and our loved ones.
    0 Yorumlar 0 hisse senetleri 806 Views
  • STRESS-
    Design With All Your Senses.
    Being is more than seeing.
    Reviewed by Ekua Hagan

    KEY POINTS-
    A person's dominant sense affects how they experience a particular space.
    Designing a space solely based on looks is not enough to create a fully supportive experience.
    Certain design materials may have unexpected downsides that aren't revealed until the designer tries them out.
    Each of us has a dominant sense. That dominant sense significantly affects how the world around us influences our thoughts and behavior.

    For a lot of us, our dominant sense is vision.
    That means, as start to put the design for a space together, many of us get caught up in what it will look like—which is not surprising since we often seek design inspiration by reviewing options online and in design magazines.

    However, vision is not the only sensory route from outside our heads to inside them. Many people experience the world through other sensory channels—they hear things and feel textures, for instance.

    Regardless of the specific set of operational sensory apparatus we have, we combine the inputs we gather about our physical environment into one holistic impression. Then, we consciously come up with a plan for how to think and behave wherever we are.

    Consider the full range of experiences in your space
    When developing a space, keeping in mind the full range of experiences people will have in it will determine if you generate an alternative that simply excels on one parameter (for example, it “photographs well”) or an area that supports the life you planned.

    A marble floor that’s lovely to look at can lead to annoying sounds as people walk across it. (For example, consider the clip of high-heeled shoes or the screech of sneakers.) A natural fiber that seems like the perfect fabric for the sofa, because it blends so well with the wallpaper, may be incredibly itchy under the elbows resting on the arms of that sofa. Or, perhaps even worse, it may not have a “positive” smell—for example, it may inherently smell like a wet dog or capture and retain the smell of any wet dog that happens to travel by it.

    Spend time with your design materials first
    It's best not to mentally commit to designing with something until you’ve spent at least a little bit of time in its presence—that’ll likely be enough to alert you to squeaky, itchy, and stinky stuff, for instance. Spending time with something before “working it in” can be difficult now that online shopping is such a big part of our lives, so be alert to return policies. Having to keep using something that’s unpleasant to spend time around can destroy your well-being.

    Not all sensory consequences will be obvious
    Bear in mind that not all of the bad sensations that tag along with the good ones will necessarily broadcast their undesirable presence.

    An example: A chair that looks wonderful, positioned in the middle of a space with people walking in front of and behind it, won’t be an A+ place to be when the person sitting in it can hear movement behind them as they sit. Sensing movement behind us is stressful; when we were a young species, things behind us might have been getting ready to eat us, and our brains have not forgotten that. The visuals of that chair position and the sounds of someone actually sitting in it don’t align. (The more subtle lesson here: Layouts/floorplans have sensory consequences.)

    Design for all of your senses so you can spend time in places where you and others live the lives that you’ve planned.
    STRESS- Design With All Your Senses. Being is more than seeing. Reviewed by Ekua Hagan KEY POINTS- A person's dominant sense affects how they experience a particular space. Designing a space solely based on looks is not enough to create a fully supportive experience. Certain design materials may have unexpected downsides that aren't revealed until the designer tries them out. Each of us has a dominant sense. That dominant sense significantly affects how the world around us influences our thoughts and behavior. For a lot of us, our dominant sense is vision. That means, as start to put the design for a space together, many of us get caught up in what it will look like—which is not surprising since we often seek design inspiration by reviewing options online and in design magazines. However, vision is not the only sensory route from outside our heads to inside them. Many people experience the world through other sensory channels—they hear things and feel textures, for instance. Regardless of the specific set of operational sensory apparatus we have, we combine the inputs we gather about our physical environment into one holistic impression. Then, we consciously come up with a plan for how to think and behave wherever we are. Consider the full range of experiences in your space When developing a space, keeping in mind the full range of experiences people will have in it will determine if you generate an alternative that simply excels on one parameter (for example, it “photographs well”) or an area that supports the life you planned. A marble floor that’s lovely to look at can lead to annoying sounds as people walk across it. (For example, consider the clip of high-heeled shoes or the screech of sneakers.) A natural fiber that seems like the perfect fabric for the sofa, because it blends so well with the wallpaper, may be incredibly itchy under the elbows resting on the arms of that sofa. Or, perhaps even worse, it may not have a “positive” smell—for example, it may inherently smell like a wet dog or capture and retain the smell of any wet dog that happens to travel by it. Spend time with your design materials first It's best not to mentally commit to designing with something until you’ve spent at least a little bit of time in its presence—that’ll likely be enough to alert you to squeaky, itchy, and stinky stuff, for instance. Spending time with something before “working it in” can be difficult now that online shopping is such a big part of our lives, so be alert to return policies. Having to keep using something that’s unpleasant to spend time around can destroy your well-being. Not all sensory consequences will be obvious Bear in mind that not all of the bad sensations that tag along with the good ones will necessarily broadcast their undesirable presence. An example: A chair that looks wonderful, positioned in the middle of a space with people walking in front of and behind it, won’t be an A+ place to be when the person sitting in it can hear movement behind them as they sit. Sensing movement behind us is stressful; when we were a young species, things behind us might have been getting ready to eat us, and our brains have not forgotten that. The visuals of that chair position and the sounds of someone actually sitting in it don’t align. (The more subtle lesson here: Layouts/floorplans have sensory consequences.) Design for all of your senses so you can spend time in places where you and others live the lives that you’ve planned.
    0 Yorumlar 0 hisse senetleri 2721 Views